EUVIMEDEUVIMED entdecken
Open Access

Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis

Arash Heidari, Rupam Sharma, Qusai Shakir, Madiha Shah, Josh Clement, Monica A Donnelley, Trina Reynolds, Kate Trigg, Jeff Jolliff, Rasha Kuran, Royce Johnson, George R Thompson

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Arash Heidari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Kern Medical Center-University of California-Los Angeles, Bakersfield, California, USA. Hauptthemen laut MEDLINE: Coccidioidomycosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, Astellas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coccidioidomycosis is a fungal infection with a range of clinical manifestations. Currently used antifungal agents exhibit variable efficacy and toxicity profiles that necessitate evaluation of additional therapeutic options. Improvement was observed in the majority of patients treated with isavuconazole, with clinical failures observed only in those with coccidioidal meningitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoccidioidomycosisHumansCoccidioidesTriazolesAntifungal AgentsNitrilesPyridines

Stichwörter der Autor:innen

CoccidioidesValley feverantifungalisavuconazoniumtreatment

Substanzen

TriazolesAntifungal AgentsisavuconazoleNitrilesPyridines

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, Kern Medical Center-University of California-Los Angeles, Bakersfield, California, USA.
  • Valley Fever Institute, Bakersfield, California, USA.
  • Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
  • Department of Pharmacy, University of California-Davis Medical Center, Sacramento, California, USA.
  • Department of Internal Medicine, Division of Infectious Diseases, University of California-Davis Medical Center, Sacramento, California, USA.
  • Department of Medical Microbiology and Immunology, University of California-Davis, Davis, California, USA.

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • Astellas
  • University of California–Davis Medical Center
  • NIH

Zitieren

APA

Heidari, A., Sharma, R., Shakir, Q., Shah, M., Clement, J., Donnelley, M. A., Reynolds, T., Trigg, K., Jolliff, J., Kuran, R., Johnson, R., & Thompson, G. R. (2023). Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad146

Vancouver

Heidari A, Sharma R, Shakir Q, Shah M, Clement J, Donnelley MA, et al. Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad146

BibTeX
@article{Heidari2023,
  author = {Heidari, Arash and Sharma, Rupam and Shakir, Qusai and Shah, Madiha and Clement, Josh and Donnelley, Monica A and Reynolds, Trina and Trigg, Kate and Jolliff, Jeff and Kuran, Rasha and Johnson, Royce and Thompson, George R},
  title = {Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad146}
}
Kostenlos starten →